pyridazine has been researched along with Acute Myelogenous Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Břehová, P; Chalupský, K; Dejmek, M; Dolníková, A; Dračínský, M; Dvořáková, A; Gucký, T; Jorda, R; Kinnertová, M; Klener, P; Kovalová, M; Kryštof, V; Mertlíková Kaiserová, H; Nencka, R; Řezníčková, E; Šála, M; Škach, K; Strmeň, T; Vojáčková, V | 1 |
1 other study(ies) available for pyridazine and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mice; Mutation; Protein Kinase Inhibitors; Pyridazines; Pyrimidines | 2023 |